8Fejerman L,Ziv E.Population differences in breast cancer severity[J].Pharmacogenomics,2008,9(3):332-333.
9Li CI,Malone KE,Daling JR.Differences in breast cancer stage,treatment,and survival by race and ethnicity[J].Arch Intern Med,2003,163(1):49-56.
10Chia KS,Reilly M,Tan CS,et al.Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle:a comparative population-based study in Singapore and Sweden[J].Int J Cancer,2005,113(2):302-306.
4[1]Kristensen VN, Kure EH, Erikstein B, et al. Genetic sus ceptibility and environmental estrogen-like compounds[J]. Mutat Res, 2001,482:77-82.
5[2]Zhou BT, Conny A. Functional role of estrogen metabolism in target cells: review and perspectives[J]. Carcinogenesis, 1998,19:1-27.
6[3]Murray GI, Taylor MC, McFadyen MC, et al. Tumour specific expression of cytochrome P450 CYP1B1 [J]. Cancer Res, 1997, 57:3026-3031.
7[4]Feigelson HS, Coetzee GA, Kolonel LN, et al. A polymorphism in the CYP17 gene increases the risk of breast cancer[J]. Cancer Res, 1997,57:1063-1065.
8[5]Feigelson HS, Shames LS, Pike MC, et al. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations [J]. Cancer Res, 1998,58:585-587.
9[6]Kristensen VN, Borresen-Dale AL. Improved electrophore tic separation of polymorphic short tandem repeats in agarose gels using bis-benzimide[J]. Biotechniques, 1997, 23:634-636.
10[7]Kristensen VN, Harada N, Yoshimura N, et al. Genetic variants of CYP19 (aromatase) and breast cancer risk[J]. Oncogene, 2000,19:1329-1333.
